DE69932823D1 - Apomorphin enthaltende darreichungsformen zur verbesserung der männlichen erektilen dysfunktion - Google Patents
Apomorphin enthaltende darreichungsformen zur verbesserung der männlichen erektilen dysfunktionInfo
- Publication number
- DE69932823D1 DE69932823D1 DE69932823T DE69932823T DE69932823D1 DE 69932823 D1 DE69932823 D1 DE 69932823D1 DE 69932823 T DE69932823 T DE 69932823T DE 69932823 T DE69932823 T DE 69932823T DE 69932823 D1 DE69932823 D1 DE 69932823D1
- Authority
- DE
- Germany
- Prior art keywords
- dysfunction
- effects
- pharmaceutical forms
- apomorphine
- containing pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US102406 | 1998-06-22 | ||
US09/102,406 US6121276A (en) | 1994-04-22 | 1998-06-22 | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
PCT/US1999/014053 WO1999066916A1 (en) | 1998-06-22 | 1999-06-22 | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69932823D1 true DE69932823D1 (de) | 2006-09-28 |
DE69932823T2 DE69932823T2 (de) | 2007-03-15 |
Family
ID=22289678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69932823T Expired - Fee Related DE69932823T2 (de) | 1998-06-22 | 1999-06-22 | Apomorphin enthaltende darreichungsformen zur verbesserung der männlichen erektilen dysfunktion |
Country Status (17)
Country | Link |
---|---|
US (2) | US6121276A (de) |
EP (1) | EP1094799B1 (de) |
JP (1) | JP2002518439A (de) |
CN (1) | CN1201738C (de) |
AT (1) | ATE336234T1 (de) |
AU (1) | AU776686B2 (de) |
BR (1) | BR9911408A (de) |
CA (1) | CA2336095A1 (de) |
DE (1) | DE69932823T2 (de) |
HK (1) | HK1040179A1 (de) |
HU (1) | HUP0102834A3 (de) |
IL (1) | IL140272A (de) |
MX (1) | MXPA00012620A (de) |
NO (1) | NO20006560L (de) |
NZ (1) | NZ509438A (de) |
PL (1) | PL195119B1 (de) |
WO (1) | WO1999066916A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
US6566368B2 (en) * | 1994-04-22 | 2003-05-20 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
US6482426B1 (en) * | 1998-09-17 | 2002-11-19 | Zonagen, Inc. | Compositions for the treatment of male erectile dysfunction |
CA2435546A1 (en) * | 2001-02-08 | 2002-08-15 | Alice C. Martino | Rapid-onset medicament for the treatment of sexual dysfunction |
ES2271542T3 (es) * | 2002-02-07 | 2007-04-16 | Pharmacia Corporation | Forma de dosificacion farmaceutica para administracion por la mucosa. |
KR20040082431A (ko) * | 2002-02-15 | 2004-09-24 | 넥스메드 홀딩스 인코포레이티드 | 발기기능장애를 치료하기 위한 프로스타글란딘 조성물 |
CA2479372A1 (en) * | 2002-03-19 | 2003-10-02 | Michael Holick | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
SE0202365D0 (sv) | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
GB0221711D0 (en) * | 2002-09-19 | 2002-10-30 | Ardana Bioscience Ltd | Methods |
CA2519117C (en) | 2003-03-17 | 2010-03-02 | Neurohealing Pharmaceuticals, Inc. | High potency dopaminergic treatment of neurological impairment associated with brain injury |
US7943632B2 (en) * | 2003-03-17 | 2011-05-17 | Neurohealing Pharmaceuticals, Inc. | High potency dopaminergic treatment of neurological impairment associated with brain injury |
CA2522231A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7306812B2 (en) | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
EP1802258A4 (de) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchrone transdermale arzneiabgabe |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US20100028841A1 (en) * | 2005-04-25 | 2010-02-04 | Ellen Eatough | Mind-Body Learning System and Methods of Use |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
JP2009149524A (ja) * | 2006-03-16 | 2009-07-09 | Kyushu Univ | アルツハイマー病の予防・治療剤 |
GB2437488A (en) * | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
DE102007008853A1 (de) | 2007-02-23 | 2008-08-28 | Plath Gmbh | System und Verfahren zur Feststellung der Existenz eines Täuschfelds |
GB2448224B (en) | 2007-04-02 | 2010-09-01 | Parkinson S Inst | Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent |
US8741918B2 (en) | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
US20100035886A1 (en) | 2007-06-21 | 2010-02-11 | Veroscience, Llc | Parenteral formulations of dopamine agonists |
US20110092493A1 (en) * | 2008-09-24 | 2011-04-21 | Clark Levi | Dose-controlled transdermal promethazine compositions and methods of use |
PL2952191T3 (pl) | 2009-06-12 | 2019-02-28 | Sunovion Pharmaceuticals Inc. | Apomorfina w postaci do podawania podjęzykowego |
WO2012083269A1 (en) | 2010-12-16 | 2012-06-21 | Cynapsus Therapeutics, Inc. | Sublingual films |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
EP2545905A1 (de) * | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | Neue therapeutische Zusammensetzung mit Apomorphin als aktiver Inhaltsstoff |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
CA3019769C (en) | 2015-04-21 | 2021-10-12 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
AU2016333486B2 (en) | 2015-09-28 | 2022-02-03 | Ever Neuro Pharma Gmbh | Aqueous composition of apomorphine for subcutaneous administration |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
JP2022523564A (ja) | 2019-03-04 | 2022-04-25 | アイオーカレンツ, インコーポレイテッド | 機械学習を使用するデータ圧縮および通信 |
WO2023242355A1 (en) | 2022-06-15 | 2023-12-21 | Ever Neuro Pharma Gmbh | Apomorphine prodrugs and uses thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2818855A (en) * | 1954-02-11 | 1958-01-07 | Anthony P Miller | Surgical device |
US3885034A (en) * | 1955-09-07 | 1975-05-20 | Bayer Ag | Phenothiazine derivatives in the treatment of psychotic persons |
US3976780A (en) * | 1968-07-29 | 1976-08-24 | Societe D'etudes Scientifiques Et Industrielles L'ile-De-France | Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide |
US4127118B1 (en) * | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
US4543256A (en) * | 1982-03-17 | 1985-09-24 | Northeastern University | (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods employing it for inhibiting the effects of epileptic seizures and for prevention and treatment of duodenal ulcers |
AU1508183A (en) * | 1982-06-04 | 1983-12-08 | Beecham Group Plc | Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane |
US4687773A (en) * | 1983-03-28 | 1987-08-18 | Mclean Hospital | (+)-N-N-propylnorapomorphine and selective limbic activity |
US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
US5011992A (en) * | 1984-06-28 | 1991-04-30 | Bristol-Myers Squibb Company | Pharmacologically active substituted benzamides |
US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
US4624965A (en) * | 1984-11-15 | 1986-11-25 | Nastech Pharmaceutical Co., Inc. | Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same |
US4772459A (en) * | 1986-09-09 | 1988-09-20 | Erbamont, Inc. | Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
US4749686A (en) * | 1986-12-04 | 1988-06-07 | New York Medical College | Combinations of renal vasodilators and α1 -adrenergic or ganglionic blocking agents and methods for treating diseases |
US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
US4857553A (en) * | 1987-08-06 | 1989-08-15 | A. H. Robins Company, Incorporated | Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents |
US5102887A (en) * | 1989-02-17 | 1992-04-07 | Arch Development Corporation | Method for reducing emesis and nausea induced by the administration of an emesis causing agent |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
ES2239369T3 (es) * | 1993-03-26 | 2005-09-16 | Franciscus Wilhelmus Henricus Maria Merkus | Composiciones farmaceuticas para administracion intranasal de dihidroergotamina. |
PT758895E (pt) * | 1994-04-22 | 2000-05-31 | Univ Kingston | Formas de dosagem sublingual contendo apomorfina para uso no tratamento da disfuncao erectil |
US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
GB9700878D0 (en) * | 1997-01-17 | 1997-03-05 | Scherer Ltd R P | Dosage forms and method for ameliorating male erectile dysfunction |
-
1998
- 1998-06-22 US US09/102,406 patent/US6121276A/en not_active Expired - Fee Related
-
1999
- 1999-06-22 IL IL140272A patent/IL140272A/en not_active IP Right Cessation
- 1999-06-22 PL PL99345401A patent/PL195119B1/pl not_active IP Right Cessation
- 1999-06-22 DE DE69932823T patent/DE69932823T2/de not_active Expired - Fee Related
- 1999-06-22 MX MXPA00012620A patent/MXPA00012620A/es not_active IP Right Cessation
- 1999-06-22 AU AU47058/99A patent/AU776686B2/en not_active Ceased
- 1999-06-22 AT AT99930538T patent/ATE336234T1/de not_active IP Right Cessation
- 1999-06-22 EP EP99930538A patent/EP1094799B1/de not_active Expired - Lifetime
- 1999-06-22 JP JP2000555602A patent/JP2002518439A/ja active Pending
- 1999-06-22 CN CNB998098647A patent/CN1201738C/zh not_active Expired - Fee Related
- 1999-06-22 NZ NZ509438A patent/NZ509438A/xx unknown
- 1999-06-22 HU HU0102834A patent/HUP0102834A3/hu unknown
- 1999-06-22 BR BR9911408-9A patent/BR9911408A/pt not_active Application Discontinuation
- 1999-06-22 CA CA002336095A patent/CA2336095A1/en not_active Abandoned
- 1999-06-22 WO PCT/US1999/014053 patent/WO1999066916A1/en active IP Right Grant
-
2000
- 2000-06-29 US US09/606,919 patent/US6306437B1/en not_active Expired - Fee Related
- 2000-12-21 NO NO20006560A patent/NO20006560L/no not_active Application Discontinuation
-
2002
- 2002-03-25 HK HK01109138A patent/HK1040179A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69932823T2 (de) | 2007-03-15 |
IL140272A (en) | 2007-07-04 |
NO20006560D0 (no) | 2000-12-21 |
HUP0102834A2 (hu) | 2002-07-29 |
CN1201738C (zh) | 2005-05-18 |
HUP0102834A3 (en) | 2002-10-28 |
US6306437B1 (en) | 2001-10-23 |
NO20006560L (no) | 2001-02-22 |
CA2336095A1 (en) | 1999-12-29 |
ATE336234T1 (de) | 2006-09-15 |
NZ509438A (en) | 2003-06-30 |
EP1094799A4 (de) | 2002-05-08 |
WO1999066916A1 (en) | 1999-12-29 |
BR9911408A (pt) | 2001-12-04 |
CN1313762A (zh) | 2001-09-19 |
AU4705899A (en) | 2000-01-10 |
JP2002518439A (ja) | 2002-06-25 |
PL195119B1 (pl) | 2007-08-31 |
PL345401A1 (en) | 2001-12-17 |
MXPA00012620A (es) | 2005-11-08 |
US6121276A (en) | 2000-09-19 |
EP1094799B1 (de) | 2006-08-16 |
AU776686B2 (en) | 2004-09-16 |
HK1040179A1 (en) | 2002-05-31 |
EP1094799A1 (de) | 2001-05-02 |
IL140272A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69932823D1 (de) | Apomorphin enthaltende darreichungsformen zur verbesserung der männlichen erektilen dysfunktion | |
CA2188385A1 (en) | Dosage Forms and Method for Ameliorating Male Erectile Dysfunction | |
HUP0004347A2 (hu) | Vegyületek női szexuális diszfunkció kezelésére | |
DE60112102D1 (de) | Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen | |
ES2152412T3 (es) | Preparacion farmaceuticamente estable de oxaliplatino. | |
AU1192302A (en) | Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists | |
WO2001085154A3 (en) | Method of treating immune pathologies with low dose estrogen | |
MXPA02012763A (es) | Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus. | |
ATE92330T1 (de) | Verfahren zur erhoehung der fertilitaet bei maennchen. | |
IL146003A0 (en) | USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION | |
AU4332302A (en) | Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof | |
MXPA03003482A (es) | Tratamiento de disfuncion sexual. | |
ATE433756T1 (de) | Gelierte zusammensetzungen | |
BG105664A (en) | Use of apomophines for the treatment of organic erectile dysfunction in males | |
MXPA02009904A (es) | Derivados de apomorfina y metodos para su uso. | |
DE60010316D1 (de) | Magnesiumomeprazol | |
SE9900025D0 (sv) | Method and composition for treatment of female sexual dysfunction | |
EE200100066A (et) | Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks | |
KR960003728A (ko) | 포유류의 허파 모세관 누출을 감소시키는 방법 | |
MX9604981A (es) | Formas de dosis y metodo para aliviar las disfunciones erectiles masculinas. | |
UY26747A1 (es) | Formas de dosificacion y metodos para mejorar la disfuncion erectil masculina | |
HK1036594A1 (en) | Formulations for the transdermal administration offenoldopam. | |
UA38380A (uk) | Спосіб профілактики лімфокіст після здухвинних лімфаденектомій у онкогенікологічних хворих | |
TW200517118A (en) | Anti tumor agent | |
AU4918900A (en) | Interferon-beta use in the treatment of ewing's family of tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |